Ilika plc 214.3% potential upside indicated by Berenberg Bank

Broker Ratings

Ilika plc with ticker (LON:IKA) now has a potential upside of 214.3% according to Berenberg Bank.



Berenberg Bank set a target price of 110 GBX for the company, which when compared to the Ilika plc share price of 35 GBX at opening today (07/02/2024) indicates a potential upside of 214.3%. Trading has ranged between 25 (52 week low) and 67 (52 week high) with an average of 230,309 shares exchanging hands daily. The market capitalisation at the time of writing is £54,687,608.

Ilika plc is a United Kingdom-based company. The Company is engaged in developing and commercializing its cutting-edge solid-state batteries. The Company develops and commercializes its thin-film Stereax miniature solid-state batteries for powering implantable medical devices and industrial wireless sensors (IIoT) in specialist environments, as well as progressing the development of its large-format Goliath cells for electric vehicles (EV) and cordless appliances. It has a secured lease of approximately 1,600 square meters property for Stereax manufacturing scale-up and installed over 340 square meters clean room facility. The Company is enabling solutions for applications, such as industrial Internet of things (IoT), MedTech, electric vehicles (EV) and consumer electronics. The Company has its operations in the United States of America, China and Israel.



Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s pack design shifts focus from cells to architecture

Ilika’s solid-state cells allowed a full battery pack redesign, cutting 100 kg, lowering cost, and extending range, without compromising safety.

Ilika Plc Customer Demand Soars as Stereax Production Ramps Up with Cirtec (Video)

Graeme Purdy, CEO of Ilika plc, outlines how solid-state Stereax batteries are entering production at Cirtec—with customer-ready units already on test. Applications span implanted sensors to orthodontics, and next-gen Goliath cells are primed for delivery by year-end.

Ilika reports advancing performance across Stereax and Goliath programmes

Ilika has outlined progress for the six months to 31 October 2025, including Stereax production qualification, Goliath prototype validation, and continued development supported by grant funding.

Ilika moves closer to commercialising its large‑format solid‑state batteries

Ilika is now building large‑format solid‑state batteries with industrial equipment as it moves closer to commercial EV adoption.

A distinct approach to scaling new battery technology

Ilika is turning heads with its selective partnerships and strategic IP model, quietly reshaping expectations for solid-state battery adoption.

Ilika Drives Forward in Solid-State Battery Revolution

With strong technical progress and scalable manufacturing, Ilika is positioned to meet growing demand in medical, IoT, and automotive sectors.

Search

Search